Personalized medicine is a rapidly evolving and growing field. The shift from one-size-fits-all medicine to a more targeted, individualized approach has broad implications for the healthcare supply chain and its supporting services. The whitepaper defines the different types of personalized medicine, while analyzing the unique supply chains and patient/provider services required to support their distribution, and ultimately, administration to patients. Drawing on interviews with U.S. specialty distributors and pharmaceutical manufacturers, this resource includes perspectives on the current and future state of the personalized medicine supply chain, and additional insights through secondary research.